1-(3-(4-(4-CYANOPHENYL)THIAZOL-2-YL)-2-(2,5-DIFLUOROPHENYL)-2-HYDROXYBUTYL)-4-(1-(((3-(HYDROXYMETHYL)PYRIDIN-2-YL)(METHYL)CARBAMOYL)OXY)ETHYL)-1H-1,2,4-TRIAZOL-4-IUM
UNII YB336T2H52
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-(3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-(((3-(hydroxymethyl)pyridin-2-yl)(methyl)carbamoyl)oxy)ethyl)-1h-1,2,4-triazol-4-ium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YB336T2H52.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C32H30F2N7O4S MJWSCYYSSOVPSI-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-(3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-(((3-(hydroxymethyl)pyridin-2-yl)(methyl)carbamoyl)oxy)ethyl)-1h-1,2,4-triazol-4-ium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.